The 35th All-Ireland Schools of Pharmacy Conference will be hosted by the University of Ulster for the first time, on March 25 and26, 2013.
This prestigious event will take place on the Belfast campus and follows the recent establishment ofUlster’s School of Pharmacy and Pharmaceutical Sciences.
The conference, which this year receives funding from Warner Chilcott and Glaxo Smith Kline, is an annual event attended by postgraduate students and academic staff from across Ireland.
It facilitates the sharing of knowledge and the collaboration of research between the five pharmacy schools in Ireland, namely the University of Ulster, Royal College of Surgeons in Ireland, Trinity College Dublin, University College Cork and Queen’s University Belfast.
The head of School of Pharmacy and Pharmaceutical Sciences, Professor Paul McCarron, said:“The University of Ulster Pharmacy Department welcomed its first students in 2009 and in November 2012 became the School of Pharmacy and Pharmaceutical Sciences.
“We are delighted to host the 35th All-Ireland Schools of Pharmacy Conference and although the School is situated on the Coleraine campus, the two-day event will take place on the Belfast campus, to make it more accessible.
“The conference will be a mix of short lectures and poster presentations on all aspects of pharmacy research.
“It will comprise of reports on synthetic pharmaceutical chemistry, dosage form design, pedagogical theory and pharmacy practice.
“The comprehensive programme is indicative of the breadth of work of international standing and quality currently underway in the various schools across Ireland.
“For many postgraduate students in Pharmacy, the All-Ireland conference has been an early opportunity to present their work to a supportive and encouraging audience comprising peers and academic staff.
“It isa unique opportunity for Ireland’s Pharmacy Schools to come together and forge relationships, collaborations and share ideas."
The School of Pharmacy and Pharmaceutical Sciences boasts state-of-the-art facilities on the Coleraine campus and has developed strong relationships with pharmaceutical firms and community pharmacies.
Ulster students learn the basic sciences that underpin the development of medicines and gain vital clinical experience to enable them to dispense and possibly prescribe medicines in the future.
As the University prepared to host the conference, Ryan Loughlin, Senior Formulation Scientist withWarner Chilcott said: “Warner Chilcott is proud to sponsor the 35th All Ireland Schools Pharmacy Conference.
“Warner Chilcott endeavours to recruit the best pharmaceutical graduates to add to our pharmaceutical team which is based at our research and development site in Larne.
“This conference is an excellent opportunity for Warner Chilcott to increase its profile among perspective pharmaceutical graduates.”
Conference organiser,Natalie Craythorne said: “The All-Ireland Schools Conference is an excellent opportunity for postgraduate students to integrate and learn from each other and forge professional relationships.
“I am very proud to be organising such an event and look forward to seeing the work presented by my fellow PhD students.”
The 35th All-Ireland Schools of Pharmacy Conference takes place on Monday & Tuesday March 25 & 26, 2013, at the University of Ulster, York Street, Belfast. For further information go to: www.ulster.ac.uk/pharmacyconference
Notes to Editors:
About Warner Chilcott
Warner Chilcott is a global specialty pharmaceutical company currently focused on the gastroenterology, women's healthcare, dermatology and urology segments of the North American and Western European pharmaceuticals markets.
Since being spun out of Warner-Lambert in 1996, Warner Chilcott has evolved, through a series of acquisitions and divestitures, from a small seller of undifferentiated products to a fully integrated pharmaceutical company with a broad portfolio of leading branded products.
The acquisition of The Procter & Gamble Company's global branded pharmaceuticals business on October 30, 2009 transformed Warner Chilcott into a global pharmaceuticals company with significant scale and geographic reach.
Today, Warner Chilcott has an expanded sales force and infrastructure to better promote products in the U.S., major Western European and other markets, increased diversity of revenue sources, enhanced product development capabilities and a deeper product development pipeline.
Headquartered in Dublin, Ireland, Warner Chilcott has employees in 12 countries in North America and Western Europe.
The Company's manufacturing facilities are located in Puerto Rico, Northern Ireland and Germany. Warner Chilcott is listed on the Nasdaq Stock Exchange and trades under the symbol WCRX.